Stockwinners Market Radar for March 17, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:00 EDT Bed Bath & Beyond to hold special shareholder meeting to approve reverse split - Bed Bath & Beyond announced that it plans to hold a special meeting of shareholders to seek approval to amend the company's Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of the company's common stock, par value $0.01 per share, at a ratio in the range of 1-for-5 to 1-for-10, with such ratio to be determined at the discretion of the Board. Holders of record of the Common Stock as of the close of business on March 27 will be entitled to notice of and to vote at the special meeting. The time, location, and other details regarding the special meeting, will be communicated to shareholders at a later date via proxy materials that have been filed with, and are subject to review by, the SEC.

17:19 EDT Novartis terminates collaboration and license pact with Sangamo - According to a regulatory filing, on March 13, 2023, Novartis Institutes for BioMedical Research, Inc. (NVS) notified Sangamo Therapeutics (SGMO) of its termination for convenience, effective June 11, 2023, of the Collaboration and License Agreement by and between Novartis and Sangamo dated July 27, 2020, pursuant to which Novartis and Sangamo were engaged in programs to research gene regulation therapies to treat three neurodevelopment disorders. Novartis has indicated to Sangamo that the termination relates to a recent strategic review. Sangamo will investigate alternative options to advance the neurodevelopmental disorder programs that were subject to the Novartis Agreement, including potential development internally or with a collaboration partner, dependent on the outcome of a broader strategic review of its pre-clinical pipeline of therapies to treat patients suffering from central nervous system disorders.

17:04 EDT Ritchie Bros. Chief Revenue Officer, Kari Taylor, to leave company on April 3 - In a regulatory filing, Ritchie Bros. announced that Kari Taylor, Chief Revenue Officer, will be leaving the company effective April 3.

16:47 EDT Tattooed Chef to delay filing Form 10-K - Tattooed Chef announced that it has filed a Form 12b-25 with the U.S. SEC to report that it will not be able to file its Annual Report on Form 10-K for the year ended December 31, 2022 by its due date and that it is not expected to do so within the 15-day extension period permitted by Rule 12b-25. The company expects cash at December 31, 2022 of approximately $6M. The company continues to require additional debt or equity capital and is pursuing multiple paths of opportunity to raise such capital as soon as practicable. The company is working diligently to file its Form 10-K with the SEC as soon as practicable.

16:41 EDT Connect Biopharma jumps 41% to $1.55 after positive Phase 2b CBP-201 data

16:32 EDT Granite acquires Brunswick Canyon quarry and asphalt plant in Nevada - Granite has purchased the high-quality aggregate-producing Brunswick Canyon quarry and asphalt plant in Carson City, Nevada. The acquisition supports Granite's vertically integrated business in Northern Nevada, aligning with the Nevada Region's home market strategy. Brunswick Canyon has produced aggregates in the region for over 50 years. In addition to its renowned aggregate offerings, the high-quality hard rock quarry boasts an on-site 400-ton-per-hour asphalt plant as it serves Carson City, South Reno, Tahoe, and the Highway 395 corridor.

16:03 EDT Guild Mortgage expands reverse mortgage division - Guild Mortgage said it added an experienced reverse mortgage leadership team to expand its reverse mortgage division through its recent acquisition of Cherry Creek Mortgage. Guild will integrate reverse mortgages into its traditional mortgage platform. The division will use Guild's large existing retail team in some 300 branches throughout the U.S. to expand reverse mortgage offerings to more borrowers nationwide. It will offer turnkey wholesale and correspondent solutions to other lenders wanting to enter the reverse mortgage space. "The combination of proprietary technology and the broad and established retail network gives Guild the opportunity to advance as a leading retail, wholesale and closed loan purchaser of reverse mortgages," said Bruce Barnes, managing director of reverse mortgages for Guild Mortgage, who joined the company from Cherry Creek. "We believe having the ability to securitize and service the reverse mortgage product will continue to strengthen our offerings and help us to serve more borrowers nationwide."

16:00 EDT PepGen Inc trading resumes

15:59 EDT Kineta Inc. trading halted, volatility trading pause

15:36 EDT GX Acquisition Corp II trading resumes

15:14 EDT UFP Industries CEO Missad sells 10,000 common shares - In a regulatory filing, UFP Industries CEO Matthew Missad disclosed the sale of 10,000 common shares of the company on March 16 at a price of $79.03 per share.

14:45 EDT Western Alliance off lows after end of week update statement - The stock remains down 9% to $33.64 in afternoon trading,

14:43 EDT Western Alliance says technology deposits less than 8% of total - Western Alliance Bank said in a statement, "Deposits within our Technology and Innovation group, which has been disproportionally impacted by the recent market turbulence, represented less than 8% of total deposits as of March 16, 2023. A substantial percentage of these accounts are tied to broader banking relationships that include treasury management services and/or credit facilities that have proven to make these deposits more resilient to runoff."

14:00 EDT Trustco Bank to repurchase up to 200,000 shares of common stock - TrustCo Bank Corp NY announced that its Board of Directors has approved a stock repurchase program. Under the stock repurchase program, TrustCo may repurchase up to 200,000 shares of its common stock, or approximately 1%, of its current outstanding shares. The repurchase program will permit shares to be repurchased in open market or private transactions, through block trades, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Commission. Repurchases will be made at management's discretion over the next twelve months at prices management considers to be attractive and in the best interests of both TrustCo and its stockholders, subject to the availability of stock, general market conditions, the trading price of the stock, alternative uses for capital, and TrustCo's financial performance. Open market purchases will be conducted in accordance with applicable legal requirements.

13:46 EDT Cosmos Health to acquire ZipDoctor, terms not disclosed - Cosmos Health announced that it has entered into a definitive agreement to acquire ZipDoctor Inc. from American International Holdings Corp for an undisclosed sum. The Sale and Purchase Agreement was signed on March 17, 2023, and the transaction is expected to close on April 3, 2023. ZipDoctor Inc., a wholly owned subsidiary of American International Holdings Corp., is a direct-to-consumer subscription-based telemedicine platform. Greg Siokas, Chief Executive Officer of Cosmos Health stated: "We are extremely pleased to announce that we have completed the next step by signing the SPA. The closing date has been scheduled for April 3, 2023, and we eagerly anticipate welcoming ZipDoctor to the Cosmos Health family of companies. We would like to thank Jacob Cohen for his cooperation and assistance in closing this transaction. The telehealth industry is set for strong growth, and we believe that ZipDoctor, with the proper investment from Cosmos Health, can become a significant player in the space. Furthermore, we intend to expand on ZipDoctor's current primary care and mental health service offerings to include the ability to speak to a doctor to seek additional medical treatments related to and including men's and women's health and wellness issues, weight loss and other similar treatments."

13:28 EDT Charles Schwab reports $16.5B in core net new assets over past five trading days - Charles Schwab announced it has seen "strong" inflows from clients over the last week. "Over the past five trading days of 3/10/23-3/16/23, clients have continued to bring assets to Schwab, with approximately $16.5 billion in core net new assets for the week, demonstrating the trust clients place in Schwab. Charles Schwab remains a safe port in a storm, driven by its conservative balance sheet, strong liquidity position, and diversified base of over 34 million account holders who invest with Charles Schwab every day. We are confident in our approach and in our ability to help clients through all kinds of economic environments," the company stated in a press release.

13:02 EDT Baker Hughes reports U.S. rig count up 8 to 754 rigs

12:00 EDT Aspen Aerogels falls -15.7% - Aspen Aerogels is down -15.7%, or -$1.23 to $6.59.

12:00 EDT First Republic falls -24.6% - First Republic is down -24.6%, or -$8.43 to $25.84.

12:00 EDT ProShares UltraShort Bloomberg Natural Gas rises 13.1% - ProShares UltraShort Bloomberg Natural Gas is up 13.1%, or $7.11 to $61.56.

11:53 EDT Biden says Congress should do more to hold bank executives accountable - President Biden in a statement said he believes Congress "can and should do more to hold senior bank executives accountable." He explained, "Congress must take action to strengthen the ability of the federal government to hold senior management accountable when their banks fail and enter FDIC receivership. Specifically, when banks fail because of mismanagement and excessive risk taking, it should be easier for regulators to claw back compensation from executives, to impose civil penalties, and to ban executives from working in the banking industry again." Already, key executives that ran Silicon Valley Bank (SIVB) and Signature Bank (SBNY), the two banks now under Federal Deposit Insurance Corporation receivership, have been removed, and investors in these two banks will take losses, the President pointed out. "Specifically, when banks fail because of mismanagement and excessive risk taking, it should be easier for regulators to claw back compensation from executives, to impose civil penalties, and to ban executives from working in the banking industry again," Biden said.

11:36 EDT Maxpro Capital Acquisition Corp trading halted, volatility trading pause

11:32 EDT Direct Selling enters letter of intent to merge with urban mobility company - Direct Selling Acquisition announced that it has entered into a non-binding letter of intent for a potential business combination with a private company in the urban mobility sector. "No assurances can be made that the Company will successfully negotiate and enter into a definitive agreement for a business combination or that the Company will be successful in completing the business combination," Direct Selling Acquisition said in a statement.

11:24 EDT WeWork says agreements result in funding and capital commitments of over $1B - WeWork (WE) earlier today announced that it has entered into a series of agreements with an ad hoc group representing over 60% of the company's public bonds, a third-party investor, and SoftBank's Vision Fund II (SFTBY), which will provide the company with an improved and sustainable balance sheet. The ad hoc group includes funds and accounts managed by King Street Capital Management, L.P., funds and accounts managed by BlackRock, funds and accounts managed by Brigade Capital Management, and other leading financial institutions. "Collectively, the transactions announced today will reduce WeWork's net debt by approximately $1.5 billion at closing, extend a significant maturity wall from 2025 to 2027, and result in new funding and new and rolled capital commitments of over $1.0 billion once completed. Following the completion of the transactions, the company is expected to be fully capitalized for the business plan filed in conjunction with today's announcement. Broad support for the comprehensive agreement demonstrates investors' and stakeholders' conviction in WeWork's business plan and growth strategy," the company stated.

11:20 EDT WeWork announces transactions to 'strengthen capital structure' - In a regulatory filing, WeWork reported that the company announced "various transactions intended to strengthen its capital structure" by restructuring its outstanding debt and raising additional capital. The company intends to hold a special meeting of its stockholders in order to approve certain of the transactions, including, among other things, the issuance of shares of the company's Class A common stock, in connection with the exchange offers and the SoftBank (SFTBY) exchange for purposes of the rules of the New York Stock Exchange, as well as to approve an amendment to the company's second amended and restated certificate of incorporation to increase the total number of shares of Class A Common Stock that the company will have authority to issue. The company, WeWork Companies, WW Co-Obligor Inc. and certain other direct and indirect subsidiaries of the issuer entered into a transaction support agreement with certain affiliates of SoftBank Group and affiliates, collectively, the "SoftBank Holders," and certain eligible holders representing approximately 57% of the aggregate principal amount outstanding of the Issuers' 7.875% Senior Notes due 2025 and approximately 68% of the aggregate principal amount outstanding of the Issuers' 5.00% Senior Notes due 2025, Series II, collectively representing approximately 62% of the aggregate principal amount outstanding of the Old Notes. Reference Link

10:11 EDT YouTube restores Donald Trump's channel - YouTubeInsider, the official YouTube account for updates to the press and media, tweeted: "Starting today, the Donald J. Trump channel is no longer restricted and can upload new content. We carefully evaluated the continued risk of real-world violence, while balancing the chance for voters to hear equally from major national candidates in the run up to an election... This channel will continue to be subject to our policies, just like any other channel on YouTube." Reference Link

10:00 EDT Bank United Corporation falls -8.8% - Bank United Corporation is down -8.8%, or -$1.47 to $15.18.

10:00 EDT First Republic falls -21.9% - First Republic is down -21.9%, or -$7.52 to $26.75.

10:00 EDT FedEx rises 9.0% - FedEx is up 9.0%, or $18.45 to $222.50.

09:56 EDT Cogent Biosciences treatment of mastocytosis granted orphan status - Cogent Biosciences' treatment of mastocytosis was granted orphan status by the FDA, according to a posting to the agency's website. Reference Link

09:47 EDT Biotie Therapies falls -6.6% - Biotie Therapies is down -6.6%, or -$1.59 to $22.41.

09:47 EDT First Republic falls -16.7% - First Republic is down -16.7%, or -$5.73 to $28.54.

09:47 EDT XPeng rises 10.8% - XPeng is up 10.8%, or 90c to $9.23.

09:45 EDT Lifecore Biomedical trading resumes

09:40 EDT Western Alliance trading resumes

09:35 EDT Lifecore Biomedical trading halted, volatility trading pause

09:35 EDT First Republic trading halted, volatility trading pause

09:29 EDT Overseas Shipholding announces 10M share repurchase plan - Overseas Shipholding announced that its board of directors has authorized a program to purchase up to ten million shares of the company's common stock. Sam Norton, OSG's president and CEO, stated, "Share repurchases remain one of several focus points for use of free cash flow generated by current and anticipated vessel operations. Reauthorization of a share repurchase program by the OSG Board of Directors provides the Company with added flexibility to continuously evaluate opportunities to manage our available cash in manners that we believe will best serve our shareholders."

09:25 EDT Pear Therapeutics to explore strategic alternatives - Pear Therapeutics announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value. The company has engaged MTS Health Partners to act as the company's exclusive financial advisor to assist in evaluating potential alternatives. MTS Health Partners is a leading boutique investment bank that provides strategic and financial advice to the healthcare industry. As part of its process, Pear is exploring the potential for an acquisition, company sale, merger, divestiture of assets, licensing, or other strategic transactions and/or seeking additional financing. There is no set timetable for this process and there can be no assurance that this process will result in the company pursuing a transaction or that any transaction, if pursued, will be completed on attractive terms. If the company is unable to complete a transaction, it may be required to seek a reorganization, liquidation or other restructuring. The company does not expect to disclose or provide an update concerning developments related to this process unless or until the company's board of directors has approved a definitive course of action or otherwise determines that other disclosure is necessary or appropriate.

09:17 EDT Primo Water says director nomination notice from Legion Partners is invalid - Primo Water announced that the notice submitted by Legion Partners Holdings, purporting to nominate four candidates to stand for election to Primo Water's Board at the company's 2023 Annual and Special Meeting, is invalid because it contains intentional misrepresentations and patently false information. Accordingly, the company will not recognize Legion's nominations at the Annual Meeting.

09:14 EDT Diana Shipping announces time charter contract for m/v Leonidas P.C. - Diana Shipping has entered into a time charter contract with Cargill International S.A., Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Leonidas P. C. The gross charter rate is $17,000 per day, minus a 4.75% commission paid to third parties, for a period of minimum eleven months to maximum thirteen months. The "Leonidas P. C." is a 82,165 dwt Kamsarmax dry bulk vessel built in 2011. The employment of "Leonidas P. C." is anticipated to generate approximately $5.61M of gross revenue for the minimum scheduled period of the time charter.

09:10 EDT Pear Therapeutics trading halted, news pending

09:06 EDT PureCycle Technologies, Mitsui & Co. announce signed heads of agreement - PureCycle Technologies and Mitsui & Co. Ltd. announced a signed heads of agreement to develop and operate a polypropylene recycling plant in Japan. Mitsui is a global trading and investment company with a diversified business portfolio based in Tokyo. In September of 2021, the two sides announced a signed memorandum of understanding. The two sides are targeting completion of a plant in 2026. The first plant is designed to transform PP waste into an ultra-pure recycled resin and expected to have an annual capacity of 59,000 metric tons.

09:05 EDT AAR Corp. elects Dietrich to its board of directors - AAR (AIR) announced that John Dietrich has been elected to AAR's Board of Directors, effective immediately. Dietrich is the President and Chief Executive Officer of Atlas Air Worldwide Holdings (AAWW) and serves as the Chairman of the National Defense Transportation Association.

09:03 EDT ADT Inc. announces $200M debt paydown - ADT Inc. announced a plan to pay down $200M in debt using cash on hand. Of the total, $150M will be achieved through a partial redemption of the $750M ADT First-Priority Senior Secured Notes due 2024 and $50M will be achieved upon the maturity of our ADT Notes due 2023. As previously announced, the ADT Notes due 2023 have been partially redeemed with $600M from our Term Loan A Facility and we expect to use an additional $50M from this facility together with $50M in cash to pay down the remaining balance.

09:02 EDT Canadian Pacific to combine with Kansas City Southern on April 14 - Canadian Pacific (CP) said that, on April 14, it will exercise the authority granted by the U.S. Surface Transportation Board's March 15 final decision and combine with Kansas City Southern (KSU) to create Canadian Pacific Kansas City, the first and only single-line railway connecting the U.S., Mexico and Canada. As previously announced, Keith Creel will become President and CEO of CPKC.

09:01 EDT Coca-Cola Europacific Partners announces annual financial report - Coca-Cola Europacific Partners filed its 2022 Integrated Report and Form 20-F with the Securities and Exchange Commission. This document was filed in accordance with Rule 5250(d) of the Nasdaq Listing Rules and includes CCEP's audited results for the year ended 31 December 2022. The unaudited fourth-quarter and full year results for the period ended 31 December 2022 were released on 16 February 2023.

08:47 EDT Chart Industries completes acquisition of Howden - Chart Industries completed its acquisition of Howden from affiliates of KPS Capital Partners. The company said, " The strategic combination of Chart and Howden expands our offering of products and solutions across the Nexus of Clean -- clean power, clean water, clean food and clean industrials. The combination also provides access to new specialty products and ESG-linked end markets such as nuclear, energy recovery and electrification. The complementary nature of the equipment and solution portfolios results in a differentiated offering across stationary and rotating equipment and is further differentiated by the additional 750 Howden engineers coming with the acquisition, doubling our global engineering team to over 1,500." Chart paid a purchase price of approximately $4.4B in cash, before customary purchase price adjustments. Chart funded the purchase price and the payment of acquisition-related expenses through a combination of cash on hand, the proceeds from previously consummated debt and equity financings and the proceeds from a tranche of term loans that closed concurrently with the acquisition. As a result of Chart's cash on hand and the debt and equity financings, the purchase price was paid solely in cash and no preferred stock was issued. Through the acquisition of Howden, Chart has gained immediate access to new customers and commercial opportunities, increasing our geographic footprint to over 35 countries. This geographic footprint allows for increased commercial and manufacturing capabilities as well as the ability to bid on projects regionally that were not previously accessible. As a result, Chart is on track to meet or exceed its previously announced targets for $175M of annualized cost synergies and $150M of commercial synergies in the first 12 months of ownership. Aftermarket, service and repair will represent approximately 30% of the combined organization with approximately 42% gross margin as a percent of sales. The increased global reach, coupled with two large existing installed bases, will result in less business cyclicality. We will also leverage Howden's digital offerings of Uptime and Ventsim across our global installed base.The new Chart executive management team will include a balance of Chart and legacy Howden executives. We will continue to operate under our "One Chart" commercial and engineering structures, further allowing us to leverage our full solution set across our diverse end markets. Both companies continue to see strong demand in the first quarter 2023. Chart's orders quarter-to-date through March 15, 2023 are above $520M Gross order intake for Howden in the fourth quarter 2022 was $534M, a new record high, and for the full year the gross order intake was $2,064M. Notable is the continued strength in the area of renewable hydrogen with orders up 47% for the full year. Backlog as of December 31, 2022 for Howden was $1.3B.

08:40 EDT Zomedica names Peter L. Donato as new CFO - Zomedica announced that it has appointed Peter L. Donato as its new CFO, effective March 16, 2023. Prior to joining Zomedica, Mr. Donato had a successful consulting practice specializing in public company readiness and was the Chief Financial Officer of Standard Bariatrics, a surgical company specializing in obesity surgery which was acquired by Teleflex in September of 2022.

08:37 EDT Corporacion America Airport reports February traffic increased 35% - Corporacion America Airport reported a 35.5% YoY increase in passenger traffic in February 2023, reaching 88.1% of February 2019 levels. Total passenger traffic grew 35.5% compared to the same month of 2022, supported by an ongoing recovery in travel demand after the Covid-19 pandemic, as reflected by higher load factors and the gradual resumption of routes and frequencies across all countries of operations. Overall passenger traffic reached 88.1% of February 2019 levels, down from the 89.9% posted in January, with international and domestic passenger traffic reaching 90.1% and 90.3% of February 2019 levels, respectively.

08:36 EDT Acer reports Phase 2 trial of ACER-801 did not achieve statistical significance - Acer Therapeutics announced that topline results from its Phase 2a proof of concept clinical trial to evaluate ACER-801 as a potential treatment for moderate to severe Vasomotor Symptoms, VMS, associated with menopause showed that ACER-801 was safe and well-tolerated but did not achieve statistical significance when evaluating ACER-801's ability to decrease the frequency or severity of hot flashes in postmenopausal women. As a result, Acer is pausing the ACER-801 program until Acer has conducted a thorough review of the full data set. Concurrently, Acer is continuing to focus on preparation for its commercial launch of OLPRUVA for oral suspension for the treatment of urea cycle disorders and the ongoing pivotal Phase 3 clinical evaluation of EDSIVO for vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation, subject in each instance to availability of additional capital beyond early in Q2 2023. "We are surprised and disappointed the Phase 2a trial did not meet its efficacy objectives in treating VMS given the extensive body of non-clinical and clinical evidence previously generated," stated Chris Schelling, CEO and Founder of Acer. "We intend to conduct a comprehensive analysis of the totality of the clinical trial data - including the pharmacokinetic data, which has not yet been analyzed - which will inform our path forward for the program, including our collaborations for prostate cancer and post-traumatic stress disorder. We wish to thank the patients, investigators and partners who participated in this clinical trial. We remain committed to our mission to provide transformative treatments to underserved and overlooked patients with rare and life-threatening diseases and will continue to focus our resources on launch preparation for our FDA-approved product, OLPRUVA, for oral suspension for the treatment of UCDs involving deficiencies of CPS, OTC or AS, as well as our pivotal Phase 3 clinical trial of EDSIVO for vEDS."

08:34 EDT Spirit AeroSystems, Astraius enter satellite launch capabilities collaboration - Spirit AeroSystems and Astraius announced a collaboration to enhance future satellite launch capabilities from Prestwick Spaceport. Spirit and Astraius - both located within Prestwick's developing space cluster - are working to advance and accelerate the system components and key processes required for the Astraius horizontal launch platform. The U.K. government has made orbital launch a priority, with the National Space Strategy outlining plans to secure an increased portion of a global space economy expected to be worth GBP 490B by 2030. The space sector in the U.K. already employs over 45,000 people, with Scotland accounting for one-fifth of that figure.

08:32 EDT Ballard Power sees FY23 CapEx $40M-$60M - Sees FY23 operating expense $135M-$155M.

08:09 EDT SVB Financial: SVB Securities, SVB Capital's funds not included in Chapter 11 - SVB Securities and SVB Capital's funds and general partner entities are not included in the Chapter 11 filing and continue to operate in the ordinary course as SVB Financial Group proceeds with its previously announced exploration of strategic alternatives for these valuable businesses. SVB Capital, a venture capital and private credit fund platform with deep roots in the innovation economy, continues to operate in the ordinary course and serve its clients. The SVB Capital funds and general partners are separate legal entities, distinct from SVB Financial Group, and are not included in the Chapter 11 filing. SVB Capital funds continue to have access to sources of funding, including subscription credit facilities and investor and general partner commitments. SVB Financial Group is committed to providing SVB Capital with support throughout the reorganization process. SVB Securities, a regulated broker-dealer with its own management, employees and capital, is a separate legal entity from SVB Financial Group and is not included in the Chapter 11 filing. It continues to operate in the ordinary course. SVB Financial Group, which owns the equity of SVB Securities, is committed to providing SVB Securities with support throughout the reorganization process. "The Chapter 11 process will allow SVB Financial Group to preserve value as it evaluates strategic alternatives for its prized businesses and assets, especially SVB Capital and SVB Securities," said William Kosturos, Chief Restructuring Officer for SVB Financial Group. "SVB Capital and SVB Securities continue to operate and serve clients, led by their longstanding and independent leadership teams. SVB Financial Group will continue to work cooperatively with Silicon Valley Bridge Bank. We are committed to finding practical solutions to maximize the recoverable value for stakeholders of both entities." SVB Financial Group plans to file customary first day motions with the Bankruptcy Court that, among other things, seek authorization to continue the operations of SVB Financial Group in the ordinary course of business as soon as a hearing can be scheduled. Additional documents relating to the Bankruptcy Court proceeding will be filed in the coming days. SVB Financial Group is no longer affiliated with Silicon Valley Bank, N.A., or the bank's private banking and wealth management business, SVB Private. The bank's successor, Silicon Valley Bridge Bank, N.A., is operating under the jurisdiction of the FDIC and is not included in the Chapter 11 filing.

08:07 EDT Vaxart to host KOL webcast on health, economic impact for norovirus - Vaxart announced it will host a key opinion leader video webcast on the health and economic impact and disease burden for norovirus on Tuesday, March 28, 2023 at 1:00 p.m. ET. The webcast will feature presentations by prominent norovirus disease experts Jan Vinje, Ph.D., Head, National Calicivirus Laboratory, Centers for Disease Control & Prevention, and Sarah Bartsch, Project Director, Public Health Informatics, Computational, and Operations Research, Research Foundation of the City University of New York. In addition, Vaxart management will provide a detailed overview of the Company's investigational norovirus oral pill vaccine program, including its two current Phase 2 clinical trials: An ongoing Phase 2 GI.1 norovirus challenge study measuring the efficacy and safety of our norovirus vaccine candidate. The study is also designed to identify a correlate of protection between immune responses to the vaccine and a reduction in risk of norovirus infection and / or severe gastroenteritis. The Company expects to report topline data from this study in Q3 2023. A Phase 2 dose-ranging study of Vaxart's bivalent norovirus oral vaccine candidate is designed to identify a vaccine dose for a potential Phase 3 clinical trial. The Company expects to report topline data from this study in mid-2023.

08:05 EDT Visionary Education to build 'Virtual Production and Education Training Center' - Visionary Education Technology Holdings announced that the Company will cooperate with the John Hughes Institute to build a "Virtual Production and Education Training Center" in Toronto, creating Canada's top virtual production and education brand. To meet the growing demand in visual production talents in Canada and North America, ensure the quality of education and the fulfillment of employment opportunities, as well as provide students with exceptional practical experiences in this field, the Company is joining forces with the John Hughes Institute, founded by Hollywood's visual effects master and Oscar-winning filmmaker John Hughes, to build the "Virtual Production and Education Training Center" in the Visionary Education Group Building Complex. The center will employ highly talented and professional faculty members, employ state of the art technologies and equipment, and utilize our modern facilities to create Canada's top virtual production education and training brand. This will serve to train more virtual production professionals in North America, providing professional services and conducting multi-faceted cooperation for students and industry corporations to meet the rapidly growing market demand. The center is scheduled to be put in use in July 2023, with a daily traffic capacity of up to 2000 students. VEDU plans to train thousands of students annually.

08:04 EDT Barrick Gold publishes 2022 annual report - The company said, "The past year marked a major milestone in Barrick's journey to becoming the world's most valued gold and copper mining company, with the foundational targets of the new business created by the Merger1 having largely been met, and its greater goals now within reach, says president and chief executive Mark Bristow with the publication of the company's 2022 annual report. "North America is Barrick's value foundation and the true benefits of our creation of the Nevada Gold Mines complex are now becoming evident in the form of mineral resource growth and new discoveries. The quality and prospectivity of its portfolio cannot be overstated," he said. "In Central America the plant expansion project we initiated at the Pueblo Viejo gold mine in the Dominican Republic is rapidly taking shape. With its unlocked reserve base now standing at 20 million ounces, the life of the mine - one of the six Tier One3 assets in our gold portfolio - has been extended beyond 2040 and it will maintain an average annual production rate above 800,000 ounces over that time. Another of our Tier One assets, the Loulo-Gounkoto complex in Mali, which has produced more than 9 million ounces of gold since 2005, is set to maintain its current rate of production for the next 10 years, with its life extending to 20375." Bristow said Barrick was also achieving its strategic objective of significantly expanding its copper holdings. Work on the reconstituted Reko Diq project in Pakistan - one of the largest and highest quality undeveloped copper-gold deposits in the world - has started, and the revitalized Lumwana mine in Zambia has commenced a pre-feasibility study on the Super Pit expansion. When both these projects are completed in 2028 they will elevate Barrick into the front rank of copper producers. "Brownfields exploration continues to unlock potential around our existing assets while greenfields work has started delivering real value. We're continuing to expand our global exploration footprint with active programs elsewhere in North America as well as in Latin America, Saudi Arabia and Egypt," he said. "One of the highlights of last year was the continued growth in our gold reserves and resources, driven by our strategy of investing in organic growth through exploration and mineral resource management. Barrick's ability over time to more than replace the ounces we mine reinforces our sustainability and our sector-leading production profile."

08:01 EDT SVB Financial commences Chapter 11 bankruptcy

07:33 EDT Zevra Therapeutics announces collaboration with RARE-X, Sleep Consortium - Zevra Therapeutics announced that it has joined the Sleep Data Initiative as a founding member. The new data collection platform is led by RARE-X and the Sleep Consortium to provide access to research-grade, patient-owned data to support the acceleration of research and treatment development for sleep disorders. "Marking World Sleep Day today, we are proud to announce this important collaboration and our role as a founding member of this significant initiative to support acceleration and advancement of sleep research programs," said Richard W. Pascoe, Chief Executive Officer of Zevra. "The data being generated by our clinical program for KP1077, our novel therapy intended for the treatment of idiopathic hypersomnia, will support the research and development of effective treatments for rare sleep disorders through the use of this vital platform." RARE-X is a research program and data collection platform sponsored by Global Genes. The platform is currently supporting 83 disease communities, with about 58 percent of participants having reported sleep disturbance as a phenotype. In addition, Zevra Therapeutics announced that U.S. Patent No. 11,505,537 from the United States Patent and Trademark Office was issued for its patent application entitled, "Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same." This patent expands Zevra's intellectual property estate for serdexmethylphenidate, which includes methods of use for methylphenidate conjugates to provide extended release of d-methylphenidate,

07:32 EDT Watsco completes $600M unsecured credit facility - Watsco signed a $600M unsecured revolving credit facility led by Bank of America, N.A. as Administrative Agent, JPMorgan Chase Bank, N.A. as Syndication Agent, and Wells Fargo Bank, National Association and U.S. Bank National Association as Documentation Agents including six other banks. In anticipation of the cessation of the London Interbank Offered Rate, this facility is linked to the new Secured Overnight Financing Rate. The new facility replaces Watsco's existing $560M unsecured revolving credit facility. Borrowings under the five-year $600M unsecured credit facility will be used for working capital, acquisitions, dividends, and other general purposes and bear interest at different rates depending on the types of advances or loans the Company selects. Terms of the agreement include increased borrowing capacity, covenant flexibility, and greater sensitivity to the seasonal nature of our working capital requirements.

07:15 EDT Bruker receives order for two Avance nuclear magnetic resonance spectrometers - Bruker announced that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance nuclear magnetic resonance spectrometers for the University of Warwick and the University of Birmingham. Each institution already has a Bruker 1.0 GHz NMR spectrometer and will advance their capabilities further for research into the materials properties for energy storage and biofuels, as well as into structures and interactions of biomolecules such as proteins, nucleic acids, carbohydrates, lipids, and metabolites. System installations are expected in 2025, and scientists from across the UK will have access, while students can gain experience at the forefront of research.

07:05 EDT Asante Gold appoints David Anthony, Edward Nana Yaw Koranteng to board - Asante Gold Corporation announces the appointment of David Anthony, CEO of Asante, and Edward Nana Yaw Koranteng, CEO of Minerals Income Investment Fund, to the Company's board of directors and the resignation of Nadia Abdul Aziz as a director of the Company, all with immediate effect.

07:03 EDT Predictive Oncology, Cancer Research Horizons announce partnership - Predictive Oncology together with Cancer Research Horizons announce that they have partnered to drive the development of oncology drugs utilizing Predictive Oncology's PEDAL platform. "Our collaboration with Cancer Research Horizons represents a fundamental shift in drug discovery that could lead to the accelerated development of cancer therapies using compounds originating from the CRUK network and developed by Cancer Research Horizons in partnership with their global network," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "We now have the ability to impact the most critical stage of early drug discovery in a way that has never been done before." The collaboration will utilize Predictive Oncology's PEDAL technology to evaluate Cancer Research Horizons' pre-clinical drug inhibitors of Glutaminase in order to determine which cancer types and patient populations are most likely to respond to treatment with these compounds. PEDAL is an artificial intelligence and machine learning platform which makes high-confidence drug response predictions enabling a more informed selection of drug-tumor type combinations for clinical development. The agreement bridges non-profit and industry, including revenue sharing for compounds developed and offers the potential for Cancer Research Horizons to incorporate PEDAL into future drug discovery processes.

07:01 EDT Taoping receives Nasdaq minimum bid price requirement extension - Taoping announced that on March 16, it received a letter from The Nasdaq Stock Market confirming the company has been granted an additional 180 calendar day period for compliance under its minimum bid price requirement through September 11. The Additional Compliance Period was granted because the company meets the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the bid price requirement, and the company's written notice to Nasdaq of its intention to cure the deficiency during the Additional Compliance Period by effecting a reverse stock split, if necessary. The notification has no immediate effect on the listing of the company's ordinary shares, which will continue to trade uninterrupted on Nasdaq under the ticker "TAOP".

06:08 EDT XPeng announces 5,218 vehicles delivered in January - Total deliveries were 5,218 vehicles in January. Total deliveries were 6,010 vehicles in February. As of February 28, year-to-date total deliveries were 11,228 vehicles.

05:48 EDT Amazon stops selling magazines and newspapers through Kindle Newsstand - Amazon is no longer selling magazine and newspaper subscriptions through Kindle Newsstand and will stop delivering current Kindle Newsstand subscriptions in September, according to an announcement from last week. Reference Link